BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 19861565)

  • 1. Titrimetric immunohistochemical evaluation of DNA hypomethylation in uterine tumours.
    Wolk M; Martin JE
    J Clin Pathol; 2009 Nov; 62(11):1039-42. PubMed ID: 19861565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis and the expression of Bax and Bcl-2 in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Kokawa K; Shikone T; Otani T; Nakano R
    Cancer; 1999 Apr; 85(8):1799-809. PubMed ID: 10223575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
    Khaled A; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix.
    Dong SM; Kim HS; Rha SH; Sidransky D
    Clin Cancer Res; 2001 Jul; 7(7):1982-6. PubMed ID: 11448914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study.
    Kristensen GB; Holm R; Abeler VM; Tropé CG
    Gynecol Oncol; 1996 Jun; 61(3):378-83. PubMed ID: 8641619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA aneuploidy in invasive carcinoma of the uterine cervix.
    Kashyap V; Bhambhani S
    Indian J Pathol Microbiol; 2000 Jul; 43(3):265-9. PubMed ID: 11218670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA demethylation is directly related to tumour progression: evidence in normal, pre-malignant and malignant cells from uterine cervix samples.
    de Capoa A; Musolino A; Della Rosa S; Caiafa P; Mariani L; Del Nonno F; Vocaturo A; Donnorso RP; Niveleau A; Grappelli C
    Oncol Rep; 2003; 10(3):545-9. PubMed ID: 12684621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor (VDR) expression is not a prognostic factor in cervical cancer.
    Friedrich M; Meyberg R; Axt-Fliedner R; Villena-Heinsen C; Tilgen W; Schmidt W; Reichrath J
    Anticancer Res; 2002; 22(1A):299-304. PubMed ID: 12017307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Contag SA; Gostout BS; Clayton AC; Dixon MH; McGovern RM; Calhoun ES
    Gynecol Oncol; 2004 Dec; 95(3):610-7. PubMed ID: 15581972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA hypomethylation of CAGE promotors in squamous cell carcinoma of uterine cervix.
    Lee TS; Kim JW; Kang GH; Park NH; Song YS; Kang SB; Lee HP
    Ann N Y Acad Sci; 2006 Dec; 1091():218-24. PubMed ID: 17341616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic DNA methylation marker in serum of cancer patients.
    Müller HM; Fiegl H; Widschwendter A; Widschwendter M
    Ann N Y Acad Sci; 2004 Jun; 1022():44-9. PubMed ID: 15251938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitfalls in immunohistochemical validation of tumor marker expression--exemplified in invasive cancer of the uterine cervix.
    Hellberg D; Tot T; Stendahl U
    Gynecol Oncol; 2009 Jan; 112(1):235-40. PubMed ID: 18976801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a flow cytometric method to determine DNA ploidy of oesophageal cancer cells obtained by forceps biopsy samples during oesophago-gastro-duodenoscopy.
    Rickes S; Hauptmann S; Flath B; Abbenseth R; Zwiebel FM; Possinger K
    Onkologie; 2003 Feb; 26(1):32-7. PubMed ID: 12624515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric evaluation of early invasive cervical cancer.
    Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
    Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between nm23-H1 expression and lymph node metastasis and prognosis in cervical cancer].
    Huang Y; Cai S; Yu S
    Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):718-21. PubMed ID: 9772433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression.
    Soares J; Pinto AE; Cunha CV; André S; Barão I; Sousa JM; Cravo M
    Cancer; 1999 Jan; 85(1):112-8. PubMed ID: 9921982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical evaluation of tumour angiogenesis in adenocarcinoma and squamous cell carcinoma of lung.
    Sikora J; Słodkowska J; Radomyski A; Giedronowicz D; Kobos J; Kupis W; Rudzinski P
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():271-9. PubMed ID: 9337544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers.
    Simony J; Pujol JL; Radal M; Ursule E; Michel FB; Pujol H
    Cancer Res; 1990 Jul; 50(14):4382-7. PubMed ID: 2163748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancies in expression and prognostic value of tumor markers in adenocarcinoma and squamous cell carcinoma in cervical cancer.
    Lindström AK; Tot T; Stendahl U; Syrjänen S; Syrjänen K; Hellberg D
    Anticancer Res; 2009 Jul; 29(7):2577-8. PubMed ID: 19596931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.